Difference between revisions of "Template:Infobox Document"
| Line 29: | Line 29: | ||
<div class="doc-type" style="text-align:right; font-size: 2em; font-weight: bold !important; font-style: normal !important;"> {{{Type}}} </div> {{#switch: {{{Period}}} |STUPUB = <div class="doc-submitted" style="text-align: left !important;">Publication of this standard for trial use (STU) has been approved by Health Level Seven International (HL7). This STU is not an accredited | <div class="doc-type" style="text-align:right; font-size: 2em; font-weight: bold !important; font-style: normal !important;"> {{{Type}}} </div> {{#switch: {{{Period}}} |STUPUB = <div class="doc-submitted" style="text-align: left !important;">Publication of this standard for trial use (STU) has been approved by Health Level Seven International (HL7). This STU is not an accredited | ||
American National Standard. The comment period for use of this STU shall end 24 months from the date of publication. Suggestions for revision should be submitted at http://www.hl7.org/stucomments/index.cfm. Following this 24 month evaluation period, this STU, revised as necessary, will be submitted to a normative ballot in preparation for approval by ANSI as an American National | American National Standard. The comment period for use of this STU shall end 24 months from the date of publication. Suggestions for revision should be submitted at http://www.hl7.org/stucomments/index.cfm. Following this 24 month evaluation period, this STU, revised as necessary, will be submitted to a normative ballot in preparation for approval by ANSI as an American National | ||
| − | Standard. Implementations of this STU shall be viable throughout the normative ballot process and for up to six months after publication of the relevant normative standard.</div> |<div class="doc-submitted" style="text-align: right !important;">{{#if: {{{Submitted|}}}| Submitted by:<br />{{{Submitted}}}|}}</div><div class="doc-submitted" style="text-align: right !important;">{{#if: | + | Standard. Implementations of this STU shall be viable throughout the normative ballot process and for up to six months after publication of the relevant normative standard.</div> |<div class="doc-submitted" style="text-align: right !important;">{{#if: {{{Submitted|}}}| Submitted by:<br />{{{Submitted}}}|}}</div><div class="doc-submitted" style="text-align: right !important;">{{#if:{{{Sponsored|}}}| Sponsored by:<br />{{{Sponsored}}}|}}</div> }} <br />{{#if: {{{Author |}}}| {{{Author}}}|}} <!--div class="doc-status"> {{{Status}}} </div--> |
| − | |||
<!--<div class="doc-vbox"> | <!--<div class="doc-vbox"> | ||
{| cellpadding="3" | {| cellpadding="3" | ||
| Line 45: | Line 44: | ||
|} | |} | ||
--><div style="text-align: left; position: absolute; top: 230mm; width: 80%;"> | --><div style="text-align: left; position: absolute; top: 230mm; width: 80%;"> | ||
| − | + | <small> {{{Copyrighttext}}} <br /> | |
| − | + | <!-- | |
{{#switch: {{{Custodian}}} | {{#switch: {{{Custodian}}} | ||
| HL7 = {{HL7InternationalAddress}} | | HL7 = {{HL7InternationalAddress}} | ||
| {{HL7InternationalAddress}} | | {{HL7InternationalAddress}} | ||
}}--> | }}--> | ||
| − | + | </small></div> | |
| − | + | <div id="specialbottomleft"> | |
| − | |||
{{#switch: {{{Topright}}} | {{#switch: {{{Topright}}} | ||
| CDAR2_INTLPATSUMMARY_R1_D1_2017SEP = <div id="bottomleftline1">HL7 CDA® R2 Implementation Guide: International Patient Summary, Release 1</div><div id="bottomleftline2">September 2017 Ballot – © 2016-2017 Health Level Seven International. All rights reserved.</div> | | CDAR2_INTLPATSUMMARY_R1_D1_2017SEP = <div id="bottomleftline1">HL7 CDA® R2 Implementation Guide: International Patient Summary, Release 1</div><div id="bottomleftline2">September 2017 Ballot – © 2016-2017 Health Level Seven International. All rights reserved.</div> | ||
